Login to Your Account



CohBar's Alzheimer's Grant to Probe Mitochondrial Function

By Catherine Shaffer
Staff Writer

Wednesday, March 6, 2013
A grant by the Alzheimer's Drug Discovery Foundation (ADDF) will support research into the role of mitochondria in Alzheimer's disease. The award of $205,260 will go to CohBar Inc., of Pasadena, Calif., which is developing a mitochondrial peptide designed to protect neurons from dying by improving mitochondrial function, reducing inflammation, increasing insulin sensitivity and decreasing oxidative stress.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription